BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 26137395)

  • 1. CD4
    Goebel L; Grage-Griebenow E; Gorys A; Helm O; Genrich G; Lenk L; Wesch D; Ungefroren H; Freitag-Wolf S; Sipos B; Röcken C; Schäfer H; Sebens S
    Oncoimmunology; 2015 Apr; 4(4):e1000083. PubMed ID: 26137395
    [TBL] [Abstract][Full Text] [Related]  

  • 2. L1CAM promotes enrichment of immunosuppressive T cells in human pancreatic cancer correlating with malignant progression.
    Grage-Griebenow E; Jerg E; Gorys A; Wicklein D; Wesch D; Freitag-Wolf S; Goebel L; Vogel I; Becker T; Ebsen M; Röcken C; Altevogt P; Schumacher U; Schäfer H; Sebens S
    Mol Oncol; 2014 Jul; 8(5):982-97. PubMed ID: 24746181
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparative characterization of stroma cells and ductal epithelium in chronic pancreatitis and pancreatic ductal adenocarcinoma.
    Helm O; Mennrich R; Petrick D; Goebel L; Freitag-Wolf S; Röder C; Kalthoff H; Röcken C; Sipos B; Kabelitz D; Schäfer H; Oberg HH; Wesch D; Sebens S
    PLoS One; 2014; 9(5):e94357. PubMed ID: 24797069
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tumor-associated macrophages exhibit pro- and anti-inflammatory properties by which they impact on pancreatic tumorigenesis.
    Helm O; Held-Feindt J; Grage-Griebenow E; Reiling N; Ungefroren H; Vogel I; Krüger U; Becker T; Ebsen M; Röcken C; Kabelitz D; Schäfer H; Sebens S
    Int J Cancer; 2014 Aug; 135(4):843-61. PubMed ID: 24458546
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Myofibroblast-induced tumorigenicity of pancreatic ductal epithelial cells is L1CAM dependent.
    Schäfer H; Geismann C; Heneweer C; Egberts JH; Korniienko O; Kiefel H; Moldenhauer G; Bachem MG; Kalthoff H; Altevogt P; Sebens S
    Carcinogenesis; 2012 Jan; 33(1):84-93. PubMed ID: 22095073
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Initiation of Pancreatic Cancer: The Interplay of Hyperglycemia and Macrophages Promotes the Acquisition of Malignancy-Associated Properties in Pancreatic Ductal Epithelial Cells.
    Otto L; Rahn S; Daunke T; Walter F; Winter E; Möller JL; Rose-John S; Wesch D; Schäfer H; Sebens S
    Int J Mol Sci; 2021 May; 22(10):. PubMed ID: 34064969
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Up-regulation of L1CAM in pancreatic duct cells is transforming growth factor beta1- and slug-dependent: role in malignant transformation of pancreatic cancer.
    Geismann C; Morscheck M; Koch D; Bergmann F; Ungefroren H; Arlt A; Tsao MS; Bachem MG; Altevogt P; Sipos B; Fölsch UR; Schäfer H; Müerköster SS
    Cancer Res; 2009 May; 69(10):4517-26. PubMed ID: 19435915
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Crosstalk between Nrf2 and TGF-β1 in the Epithelial-Mesenchymal Transition of Pancreatic Duct Epithelial Cells.
    Arfmann-Knübel S; Struck B; Genrich G; Helm O; Sipos B; Sebens S; Schäfer H
    PLoS One; 2015; 10(7):e0132978. PubMed ID: 26226105
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diabetes as risk factor for pancreatic cancer: Hyperglycemia promotes epithelial-mesenchymal-transition and stem cell properties in pancreatic ductal epithelial cells.
    Rahn S; Zimmermann V; Viol F; Knaack H; Stemmer K; Peters L; Lenk L; Ungefroren H; Saur D; Schäfer H; Helm O; Sebens S
    Cancer Lett; 2018 Feb; 415():129-150. PubMed ID: 29222037
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The anti-oxidative transcription factor Nuclear factor E2 related factor-2 (Nrf2) counteracts TGF-β1 mediated growth inhibition of pancreatic ductal epithelial cells -Nrf2 as determinant of pro-tumorigenic functions of TGF-β1.
    Genrich G; Kruppa M; Lenk L; Helm O; Broich A; Freitag-Wolf S; Röcken C; Sipos B; Schäfer H; Sebens S
    BMC Cancer; 2016 Feb; 16():155. PubMed ID: 26915435
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Paracrine IL-6 signaling mediates the effects of pancreatic stellate cells on epithelial-mesenchymal transition via Stat3/Nrf2 pathway in pancreatic cancer cells.
    Wu YS; Chung I; Wong WF; Masamune A; Sim MS; Looi CY
    Biochim Biophys Acta Gen Subj; 2017 Feb; 1861(2):296-306. PubMed ID: 27750041
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Binding of the transcription factor Slug to the L1CAM promoter is essential for transforming growth factor-β1 (TGF-β)-induced L1CAM expression in human pancreatic ductal adenocarcinoma cells.
    Geismann C; Arlt A; Bauer I; Pfeifer M; Schirmer U; Altevogt P; Müerköster SS; Schäfer H
    Int J Oncol; 2011 Jan; 38(1):257-66. PubMed ID: 21109948
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mesenchymal-epithelial transition of pancreatic cancer cells at perineural invasion sites is induced by Schwann cells.
    Fujii-Nishimura Y; Yamazaki K; Masugi Y; Douguchi J; Kurebayashi Y; Kubota N; Ojima H; Kitago M; Shinoda M; Hashiguchi A; Sakamoto M
    Pathol Int; 2018 Apr; 68(4):214-223. PubMed ID: 29457853
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Liver metastasis of pancreatic cancer: the hepatic microenvironment impacts differentiation and self-renewal capacity of pancreatic ductal epithelial cells.
    Knaack H; Lenk L; Philipp LM; Miarka L; Rahn S; Viol F; Hauser C; Egberts JH; Gundlach JP; Will O; Tiwari S; Mikulits W; Schumacher U; Hengstler JG; Sebens S
    Oncotarget; 2018 Aug; 9(60):31771-31786. PubMed ID: 30167093
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of SNAIL in accompanying PanIN is a key prognostic indicator in pancreatic ductal adenocarcinomas.
    Fujiwara S; Saiki Y; Ishizawa K; Fukushige S; Yamanaka M; Sato M; Ishida M; Motoi F; Unno M; Horii A
    Cancer Med; 2019 Apr; 8(4):1671-1678. PubMed ID: 30791220
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Presence of pancreatic intraepithelial neoplasia-3 in a background of chronic pancreatitis in pancreatic cancer patients.
    Hwang IK; Kim H; Lee YS; Kim J; Cho JY; Yoon YS; Han HS; Hwang JH
    Cancer Sci; 2015 Oct; 106(10):1408-13. PubMed ID: 26183380
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Significance of High-Mobility Group A Protein 2 Expression in Pancreatic Ductal Adenocarcinoma and Ampullary Adenocarcinoma.
    Oflas D; Canaz F; Özer İ; Demir L; Çolak E
    Turk J Gastroenterol; 2023 Oct; 34(10):1014-1024. PubMed ID: 37787719
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Detailed analysis of epithelial-mesenchymal transition and tumor budding identifies predictors of long-term survival in pancreatic ductal adenocarcinoma.
    Kohler I; Bronsert P; Timme S; Werner M; Brabletz T; Hopt UT; Schilling O; Bausch D; Keck T; Wellner UF
    J Gastroenterol Hepatol; 2015 Mar; 30 Suppl 1():78-84. PubMed ID: 25827809
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical Impact of Epithelial-to-Mesenchymal Transition Regulating MicroRNAs in Pancreatic Ductal Adenocarcinoma.
    Dhayat SA; Traeger MM; Rehkaemper J; Stroese AJ; Steinestel K; Wardelmann E; Kabar I; Senninger N
    Cancers (Basel); 2018 Sep; 10(9):. PubMed ID: 30217058
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of annexin II and stromal tenascin C promotes epithelial to mesenchymal transition and correlates with distant metastasis in pancreatic cancer.
    Yoneura N; Takano S; Yoshitomi H; Nakata Y; Shimazaki R; Kagawa S; Furukawa K; Takayashiki T; Kuboki S; Miyazaki M; Ohtsuka M
    Int J Mol Med; 2018 Aug; 42(2):821-830. PubMed ID: 29749431
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.